PARIS, Jan 28 — Clinical trials in the United States and China have shown that a new gene-based test for patients with lung cancer beats standard methods in predicting survival, researchers reported yesterday. The findings, published in the British medical journal The Lancet, should help doctors to make more accurate prognoses and better choices ...